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ABSTRACT 
 
 
AIM AND OBJECTIVES: 
 
The present study is aimed at evaluating the importance of  Argyrophilic 
Nucleolar Organizer regions (AgNORs) in differentiating benign, premalignant 
and malignant lesions of the prostate and also to correlate the AgNOR count 
with histological grade in prostatic carcinoma and to evaluate AgNOR study as 
a diagnostic and prognostic marker in prostate cancer. 
MATERIALS AND METHODS: 
 
A total of  33 various prostatic lesions were studied during the period 
June 2016 to May2017 which includes benign prostatic hyperplasia, prostatic  
intraepithelial hyperplasia and prostatic adenocarcinoma.  
All those 33 prostate specimens were selected and then fixed with 10%  
formalin, embedded in paraffin and stained with haematoxylin& eosin and  
AgNOR stain. 
 
RESULTS: 
 
The incidence of Benign Prostatic Hyperplasia was highest in the study 
with 23 cases contributing to  69.7%, followed by  9  cases of prostatic 
carcinoma comprising of 27.3 % of cases and one case of Prostatic 
intraepithelial neoplasia constituting 3%. BPH was the most common lesion in 
all age groups. However the incidence of prostatic carcinoma increased in the 
age group 71-80 years constituting 44.4% and BPH constitutes 55.6% in this 
age group. In the present study, mean AgNOR count in Benign prostatic 
hyperplasia is low and found to be 1.5 whereas in prostatic adenocarcinoma it is 
highest of about 5.22 . 
From the statistical analysis of the present study,  p value was <0.05 .  
AgNOR staining is found to be both sensitive and specific marker to distinguish 
benign and malignant prostatic lesions. 
 
CONCLUSION: 
 
AgNORs proves to be a simple,inexpensive , reliable method among 
other proliferative markers and can be used along with haematoxylin and eosin 
stained slides to distinguish between prostatic adenocarcinoma and benign  
prostatic lesions in doubtful cases and also in highlighting the  aggressiveness/ 
prognosis of the cancer. 
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